Ion channels are involved in diverse biological processes and play essential roles in the physiology of all cells. An increasing number of human and animal diseases have been identified as relating to the defective function of ion channels. Scorpion venoms contain various polypeptides with distinct biological functions that particularly affect the permeability of ion channels in cell membranes (Catterall 1980; Valdivia et al. 1992; Garcia et al. 1997). These polypeptides possess the potency to recognize ion channels and receptors in excitable membranes and are classified into four groups on the basis of ion-channel types: (1) group I modulates Na+-channel activity (Possani et al. 1999) and contains peptides of 60 to 70 amino acids linked by four disulfide bridges; (2) group II blocks K+ channels (Miller 1995; Romi-Lebrun et al. 1997) and are short peptides with 31 to 41 amino acid residues with three or four disulfide bonds; (3) group III supposedly inhibits Cl−channels (DeBin et al. 1993) and contains short-chain insect toxin peptides of ∼36 amino acids with four disulfide bonds; and (4) group IV includes peptides that modulate ryanodine-sensitive Ca2+ channels (Valdivia and Possani 1998). It is believed that the toxin has a unique tertiary structure that may provide valuable information for understanding channels. Thus, understanding the structural basis of the specificity of scorpion toxins for these receptors could lead to the design of new ligands with controlled activity and potency with potential for clinical applications. Scorpion K+-channel blockers of group II, named α-KTx, have been classified into 12 subfamilies (Miller 1995; Tytgat et al. 1999). These K+-channel blockers block two major classes of K+ channels: voltage-gated (Kv-type) and high-conductance Ca2+-activated (BK-type) K+ channels. The three-dimensional structures of several scorpion K+-channel blockers have been determined by NMR spectroscopy; these include charybdotoxin (ChTx; Bontems et al. 1991), iberiotoxin (IbTx; Johnson et al. 1992), noxiustoxin (NTx; Dauplais et al. 1995), PO5-NH2 (Meunier et al. 1993), kaliotoxin (KTx; Fernandez et al. 1994), margatoxin (MgTx; Johnson et al. 1994), and tityustoxin K-α (TsTx-Kα; Ellis et al. 2001). Although the overall fold of these α-KTx toxins is very similar, there are subtle variations among them in amino acid sequence, the size of the β-sheet, the type of β-turn, or the type of α-helix (i.e., α-helix versus 310-helix). These differences in toxin structure affect the placement of side-chain moieties. Thus, the selectivity that various scorpion toxins have for the outer vestibule of different K+ channels is typically quite distinct. Previously, Doyle et al. (1998) applied X-ray crystallographic methods to determine the three-dimensional structure of the KcsA bacterial K+ channel, which may serve as a good model for understanding the binding site of scorpion toxin on Kv-type channels. Recently, a new K+-channel blocker was identified from the scorpion venom of Tityus cambridgei (Tc1; Batista et al. 2000). Tc1 contains 23 amino acids linked with three disulfide bridges and is the smallest K+-channel blocker toxin from scorpion venoms. All previously known K+-channel blockers from scorpion venoms are longer than 30 amino acid residues and are classified into 12 subfamilies as described above. Tc1 is classified as the first member of the new subfamily 13. In K+-channel blocking activity, Tc1 recognizes the Shaker B K+ channels with a dissociation constant (Kd) of 65 nM and competes with NTx for binding to the synaptosomal membranes, with an inhibitory concentration 50% (IC50) value in the order of 200 nM (Batista et al. 2000). Tc1 is a highly basic peptide because it contains seven positively charged residues with a pI value of 9.50. The sequence alignment of Tc1 with eight other K+-channel blockers from scorpion toxins is shown in Figure 1 ▶. We found that six cysteine residues (Cys2, Cys5, Cys9, Cys15, Cys20, and Cys22), Gly13, and Lys14 (Tc1 numbering) are conserved, and the C-terminal regions are highly similar among these toxins. In addition, the sequence of Tc1 shows some unique properties. For example, Tc1 possesses Arg at position 19, whereas the corresponding residue in the other toxins is Lys. At position 16, Tc1 has Ile, whereas the other toxins, with the exception of the PO5 peptide, have Met at the corresponding position. Furthermore, Tc1 contains dense positively charged residues at residues 5–10. Unlike other scorpion toxins, Tc1 does not contain either negatively charged residues or proline. These properties make Tc1 an excellent candidate for three-dimensional structure determination and site-directed mutagenesis and for gaining clearer understanding of K+ channels. Fig. 1. Sequence alignment of Tc1 with eight other K+-channel blockers was generated using the CLUSTAL-W (Thompson et al. 1994) and ESPript (Gouet et al. 1999) programs. Three-dimensional solution structures for six of them have been determined: They are ChTx ... In this study, synthetic Tc1 was made by conventional solid-phase peptide synthesis and folded into its active conformation. We checked the channel-blocking activity of the synthesized Tc1 and found that both synthetic and native Tc1 possess similar blocking activity against the Shaker K+ channel. Next, we applied circular dichrosim (CD) and NMR techniques to solve the solution structure of Tc1. To further understand the various structure-function relationships among the K+-channel blockers from scorpion venoms, we compared the three-dimensional structure of Tc1 and those of other structurally and functionally related scorpion toxins, ChTx and NTx. We concluded that the C-terminal structure is the most important region for the blocking activity of Kv-type channels for scorpion K+-channel blockers. In addition, we also asserted that some of the residues in the larger scorpion K+-channel blockers, which contain 31 to 40 amino acids, are clearly not involved in K+-channel blocking activity.